Neoadjuvant Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
Conditions: Colon Cancer; Mismatch Repair Deficiency; Immunotherapy Interventions: Drug: Camrelizumab Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: liposomal irinotecan; Drug: Capecitabine; Radiation: Radiation threapy Sponsors: Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer
Conditions: Breast Cancer Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
Conditions: Sentinel Lymph Node Biopsy; Neoadjuvant Therapy; Breast Neoplasm Interventions: Diagnostic Test: Identification rate of sentinel lymph node for each dual method Sponsors: National Cancer Center, Korea Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
Conditions: Head and Neck Cancer Interventions: Drug: Toripalimab; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Therapy of HAIC （GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors：NEO-ERA-01 Study
Conditions: Biliary Tract Carcinoma Interventions: Drug: Adebrelimab; Drug: Lenvatinib; Drug: Gemcitabine; Drug: Cisplatin Sponsors: The First Affiliated Hospital with Nanjing Medical University; Jiangsu Hengrui Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Conditions: Neoadjuvant Immunotherapy; Cervical Cancer; Fertility-sparing Surgery Interventions: Drug: AK104; Drug: Carboplatin; Drug: Nab paclitaxel Sponsors: Xiaohua Wu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

Neo-Bio-ADAURA: A Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib
Conditions: Non-squamous NSCLC With Completely Resectable (Stage II-III) Disease With Epidermal Growth Factor Receptor (EGFR) Mutation Interventions: Drug: Osimertinib Sponsors: Jair Bar, M.D., Ph.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: Leucovorin; Drug: Oxaliplatin; Drug: Fluoruracil; Drug: Capecitabine; Radiation: Radiation Sponsors: Canadian Cancer Trials Group; Alliance for Clinical Trials in Oncology; ECOG-ACRIN Cancer Research Group; NRG Oncology; SWOG Cancer Research Network Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
Conditions: Locally Advanced Rectal Cancer Interventions: Radiation: node-sparing short-course radiotherapy; Drug: Sintilimab; Drug: Capecitabine; Drug: Oxaliplatin; Procedure: TME surgery; Procedure: watch and wait Sponsors: Jinhua Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Adebrelimab and dalpiciclib Sponsors: Zhongzheng Xiang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
Conditions: Breast Cancer Interventions: Drug: 6.0 mg/kg of TQB2102 for injection; Drug: 7.5 mg/kg of TQB2102 for injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs
Conditions: Gastric Cancer; Organoid; Neoadjuvant Therapy Interventions: Drug: Oxaliplatin Sponsors: Dong Bing Zhao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials

Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma
Conditions: Locally Advanced Gastric Adenocarcinoma Interventions: Drug: adebrelimab, S-1 and oxaliplatin; Drug: S-1 and oxaliplatin Sponsors: Yang Jianjun, PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment
Conditions: Breast Cancer Interventions: Device: Ultrasound imaging 3D and Spectroscopy Sponsors: Sunnybrook Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials